Lam Research: Down 29% Since My Sell Call, But The Math Has Changed (Upgrade)

Lam Research shares have declined 29% since the stock was previously rated Sell on high valuation, shifting the valuation landscape for LRCX. A $200 billion wafer-fabrication boom is cited as a key industry catalyst for the company's outlook.

Analysis

The key question is whether the fab-spending headline converts into Lam orders, not whether the industry has announced a large investment pool. Spending mix matters: capacity additions, advanced processes and packaging can have different tool intensity and timing, while customer project delays can defer equipment revenue even if long-run budgets remain intact. A valuation reset may improve prospective entry risk, but it does not by itself establish that earnings expectations have bottomed.

Over the next 1–3 months, watch Lam’s order commentary, customer capex revisions and the mix of memory versus logic demand. A broad, funded increase in orders would support both earnings visibility and a potential multiple recovery; concentrated or delayed projects would leave the shares exposed to estimate cuts. Applied Materials and KLA are useful relative-demand checks, but product mix makes them imperfect hedges. Export controls and any further weakening in China-related demand are downside risks; the 6–18 month upside case depends on sustained utilization and actual tool deliveries, not announcements alone.

Contrarian read: after a sharp drawdown, the market may be discounting cyclical weakness too aggressively—but the article provides no valuation, earnings or order data to establish that. No high-conviction trade is justified from this signal alone.

Key Decisions for Investors

• Keep LRCX on a catalyst watchlist rather than buying solely on the price decline. Reassess after the next earnings update for order trends, backlog conversion and management’s customer-capex outlook.
• Treat a long LRCX position as conditional on broadening, funded customer orders and stable earnings estimates; size exposure against the possibility that announced fab projects are delayed or revised.
• Monitor Applied Materials and KLA commentary as cross-checks on equipment demand. Avoid a pair trade until product-mix and relative valuation data establish a clear divergence.
• Falsification for the recovery thesis: downward revisions to customer capex or Lam’s outlook, weakening order/backlog conversion, or tighter export restrictions that materially impair demand.